Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
Fierce Pharma4h
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAPBiodexa is ...
GlobeSt8h
Williams Equities Seeks $130M for Possible Office-to-Resi Building
Williams Equities is looking to fetch around $130 million for its office Manhattan property 79 Madison Avenue, which could be ...
Global Interferons Market is Predicted to Reach ~USD 14 Billion by 2032 | DelveInsight
DelveInsight's Interferons Market Insights report provides the current and forecast market analysis, individual leading ...
XPOVIO Continues to Disrupt the Oncology Market with Expanded Indications and Strong Market Performance | DelveInsight
DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a ...
DelveInsight Business Research, LLP: Global Interferons Market is Predicted to Reach ~USD 14 Billion by 2032 | DelveInsight
The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...